Vaccines work by increasing resistance to infection and improving general health. There are different types of vaccines including live attenuated, inactivated, toxoid, subunit, and DNA vaccines. DNA vaccines offer advantages over traditional vaccines as they use only DNA from pathogens and stimulate both antibody and cellular immunity without risk of infection while not requiring refrigeration.
This presentation covers a general introduction to expression vector, its components, types, and its application. Then it covers some of the expression system with examples.
This presentation covers a general introduction to expression vector, its components, types, and its application. Then it covers some of the expression system with examples.
bacteriophages require bacterial host to complete its life-cycle, wherein site-specific genetic recombination occurs. furthermore, homologous recombination also occur in phages in case of multiple infection of the host cell.
Along the prokaryotic vectors some Eukaryotic vectors are also present. These are basically used for the expression of eukaryotic DNA of interest in the Eukaryotes
DNA vaccines (types, method and mechanism) Aneela Rafiq
DNA Vaccine is very promising method in current century. it can eliminate the risks of encountering pathogen with living cell.
this presentation has a brief concept about DNA Vaccine, to understand the baseline of genetic vaccine.
Ramachandran plot for structural validation of protein will give information whether your protein or model protein is allowed or not in three dimensional point of view.
bacteriophages require bacterial host to complete its life-cycle, wherein site-specific genetic recombination occurs. furthermore, homologous recombination also occur in phages in case of multiple infection of the host cell.
Along the prokaryotic vectors some Eukaryotic vectors are also present. These are basically used for the expression of eukaryotic DNA of interest in the Eukaryotes
DNA vaccines (types, method and mechanism) Aneela Rafiq
DNA Vaccine is very promising method in current century. it can eliminate the risks of encountering pathogen with living cell.
this presentation has a brief concept about DNA Vaccine, to understand the baseline of genetic vaccine.
Ramachandran plot for structural validation of protein will give information whether your protein or model protein is allowed or not in three dimensional point of view.
David Haselwood | How vaccines prevent diseasesDavid Haselwood
David Haselwood - Vaccines provide immunity that protects you from disease without the risk of the infection. It contains a small amount of the germs or parts of the germs that cause disease. The germs in vaccines are either killed or weakened so they can't make you sick. Therefore, vaccination plays an important role in one’s health. #DavidHaselwood
http://davidhaselwood.blogspot.in/
https://medium.com/@davidhaselwood
https://davidhaselwood.wordpress.com/
https://gust.com/companies/david-haselwood
vaccine train user immune system to create antibodies, just as it when it is exposed to a disease. However, because vaccine contain only killed or weakened forms of germs like viruses or bacteria, they do not cause the disease or put you at the risk of complications.
vaccine is a biological preparation that improve immunity to a particular disease.
A vaccine typically contain an agent that resembles a disease causing microorganisms and is often made from weakened or killed forms of the microbes.
Immunity: Protection from an infectious disease. If you are immune to a disease, you can be exposed to it without becoming infected.
Vaccine: A preparation that is used to stimulate the body’s immune response against diseases. Vaccines are usually administered through needle injections, but some can be administered by mouth or sprayed into the nose.
Vaccination: The act of introducing a vaccine into the body to produce protection from a specific disease.
A DNA vaccine is a type of vaccine that transfects a specific antigen-coding DNA sequence into the cells of an organism as a mechanism to induce an immune response.
DNA vaccines work by injecting genetically engineered plasmid containing the DNA sequence encoding the antigen(s) against which an immune response is sought, so the cells directly produce the antigen, thus causing a protective immunological response.
vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and to further recognize and destroy any of the microorganisms associated with that agent that it may encounter in the future.
HISTORY OF VACCINES-
EDWARD JENNER conduct experiments in 1796 that lead to the creation of the first smallpox vaccine for prevention of smallpox.
A vaccine for RABIES is developed by LOUIS PASTEUR .
Vaccine for COLERA and TYPHOID were developed in 1896 and PLAGE vaccine in 1887.
The first DIPHTHERIA vaccine is developed in about 1913 by EMIL ADOLPH BEHRING,WILLIAM HALLOCK PARK.
The whole cell PERTUSIS vaccines are developed in 1914.
A TETANUS vaccine is developed in 1927.
Lag phase
Adaptation, preparation for division, increase in size and density.
Log phase (logarithmic or exponential).
Max. growth rate, increase linearly with time.
Growth yield and growth rate.
Stationary phase
Depletion of nutrient, accumulation of toxic. materials, cell crowding.
Decline phase
Originally isolated from nature, but increasingly "improved" by genetic manipulation via mutagenesis and selection or recombinant DNA technology or protoplast fusion (fungi)
Transcript: Selling digital books in 2024: Insights from industry leaders - T...BookNet Canada
The publishing industry has been selling digital audiobooks and ebooks for over a decade and has found its groove. What’s changed? What has stayed the same? Where do we go from here? Join a group of leading sales peers from across the industry for a conversation about the lessons learned since the popularization of digital books, best practices, digital book supply chain management, and more.
Link to video recording: https://bnctechforum.ca/sessions/selling-digital-books-in-2024-insights-from-industry-leaders/
Presented by BookNet Canada on May 28, 2024, with support from the Department of Canadian Heritage.
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024Tobias Schneck
As AI technology is pushing into IT I was wondering myself, as an “infrastructure container kubernetes guy”, how get this fancy AI technology get managed from an infrastructure operational view? Is it possible to apply our lovely cloud native principals as well? What benefit’s both technologies could bring to each other?
Let me take this questions and provide you a short journey through existing deployment models and use cases for AI software. On practical examples, we discuss what cloud/on-premise strategy we may need for applying it to our own infrastructure to get it to work from an enterprise perspective. I want to give an overview about infrastructure requirements and technologies, what could be beneficial or limiting your AI use cases in an enterprise environment. An interactive Demo will give you some insides, what approaches I got already working for real.
"Impact of front-end architecture on development cost", Viktor TurskyiFwdays
I have heard many times that architecture is not important for the front-end. Also, many times I have seen how developers implement features on the front-end just following the standard rules for a framework and think that this is enough to successfully launch the project, and then the project fails. How to prevent this and what approach to choose? I have launched dozens of complex projects and during the talk we will analyze which approaches have worked for me and which have not.
Essentials of Automations: Optimizing FME Workflows with ParametersSafe Software
Are you looking to streamline your workflows and boost your projects’ efficiency? Do you find yourself searching for ways to add flexibility and control over your FME workflows? If so, you’re in the right place.
Join us for an insightful dive into the world of FME parameters, a critical element in optimizing workflow efficiency. This webinar marks the beginning of our three-part “Essentials of Automation” series. This first webinar is designed to equip you with the knowledge and skills to utilize parameters effectively: enhancing the flexibility, maintainability, and user control of your FME projects.
Here’s what you’ll gain:
- Essentials of FME Parameters: Understand the pivotal role of parameters, including Reader/Writer, Transformer, User, and FME Flow categories. Discover how they are the key to unlocking automation and optimization within your workflows.
- Practical Applications in FME Form: Delve into key user parameter types including choice, connections, and file URLs. Allow users to control how a workflow runs, making your workflows more reusable. Learn to import values and deliver the best user experience for your workflows while enhancing accuracy.
- Optimization Strategies in FME Flow: Explore the creation and strategic deployment of parameters in FME Flow, including the use of deployment and geometry parameters, to maximize workflow efficiency.
- Pro Tips for Success: Gain insights on parameterizing connections and leveraging new features like Conditional Visibility for clarity and simplicity.
We’ll wrap up with a glimpse into future webinars, followed by a Q&A session to address your specific questions surrounding this topic.
Don’t miss this opportunity to elevate your FME expertise and drive your projects to new heights of efficiency.
Connector Corner: Automate dynamic content and events by pushing a buttonDianaGray10
Here is something new! In our next Connector Corner webinar, we will demonstrate how you can use a single workflow to:
Create a campaign using Mailchimp with merge tags/fields
Send an interactive Slack channel message (using buttons)
Have the message received by managers and peers along with a test email for review
But there’s more:
In a second workflow supporting the same use case, you’ll see:
Your campaign sent to target colleagues for approval
If the “Approve” button is clicked, a Jira/Zendesk ticket is created for the marketing design team
But—if the “Reject” button is pushed, colleagues will be alerted via Slack message
Join us to learn more about this new, human-in-the-loop capability, brought to you by Integration Service connectors.
And...
Speakers:
Akshay Agnihotri, Product Manager
Charlie Greenberg, Host
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf91mobiles
91mobiles recently conducted a Smart TV Buyer Insights Survey in which we asked over 3,000 respondents about the TV they own, aspects they look at on a new TV, and their TV buying preferences.
PHP Frameworks: I want to break free (IPC Berlin 2024)Ralf Eggert
In this presentation, we examine the challenges and limitations of relying too heavily on PHP frameworks in web development. We discuss the history of PHP and its frameworks to understand how this dependence has evolved. The focus will be on providing concrete tips and strategies to reduce reliance on these frameworks, based on real-world examples and practical considerations. The goal is to equip developers with the skills and knowledge to create more flexible and future-proof web applications. We'll explore the importance of maintaining autonomy in a rapidly changing tech landscape and how to make informed decisions in PHP development.
This talk is aimed at encouraging a more independent approach to using PHP frameworks, moving towards a more flexible and future-proof approach to PHP development.
UiPath Test Automation using UiPath Test Suite series, part 3DianaGray10
Welcome to UiPath Test Automation using UiPath Test Suite series part 3. In this session, we will cover desktop automation along with UI automation.
Topics covered:
UI automation Introduction,
UI automation Sample
Desktop automation flow
Pradeep Chinnala, Senior Consultant Automation Developer @WonderBotz and UiPath MVP
Deepak Rai, Automation Practice Lead, Boundaryless Group and UiPath MVP
Accelerate your Kubernetes clusters with Varnish CachingThijs Feryn
A presentation about the usage and availability of Varnish on Kubernetes. This talk explores the capabilities of Varnish caching and shows how to use the Varnish Helm chart to deploy it to Kubernetes.
This presentation was delivered at K8SUG Singapore. See https://feryn.eu/presentations/accelerate-your-kubernetes-clusters-with-varnish-caching-k8sug-singapore-28-2024 for more details.
Let's dive deeper into the world of ODC! Ricardo Alves (OutSystems) will join us to tell all about the new Data Fabric. After that, Sezen de Bruijn (OutSystems) will get into the details on how to best design a sturdy architecture within ODC.
2. WhatVaccines do:WhatVaccines do:
Increase Resistance to InfectionIncrease Resistance to Infection
There are many ways to improveThere are many ways to improve
general health:general health:
1. Proper nutrition,1. Proper nutrition,
2. Exercise,2. Exercise,
3. Healthy lifestyle,3. Healthy lifestyle,
and…and…
4. Vaccination
4. A vaccine is a biological preparation that
provides active acquired immunity to a
particular disease.
A vaccine typically contains an agent that
is similar to a disease-causing
microorganism.
It is often made from weakened or killed
forms of the microbe (its toxins or one of
its surface proteins).
5. It stimulates the body's immune
system to recognize the agent in the
form of risk, destroy it, and keep a
record of it, so that the immune
system can more easily recognize
and destroy any of these
microorganisms that it later
encounters.
6. Vaccines can be prophylactic (example: to
prevent the effects of a future infection by any
natural pathogen OR therapeutic (example:
vaccines against cancer are also being
investigated).
Immunization or Vaccination: A procedure
designed to increase concentrations of
antibodies and/or effector T-cells which are
reactive against infection (or cancer).
8. Weakened (Modified Live)
Vaccines
Produced by weakening a live microorganism or
removing it’s disease-causing ability.
Advantages Disadvantages
- They produce a large
immune response
- Have to receive the
vaccine once or twice.
- They have to be kept in
special conditions, like
refrigeration.
- They can mutate and
might cause the disease.
9. Inactivated (killed)Vaccines
These vaccines are produced
by killing the infectious agent.
Advantages Disadvantages
- They do not have to
be refrigerated.
- They will never come
back to life and cause
the disease.
- They usually require
booster shots because
they only weakly
stimulate the immune
system to make
antibodies.
10. Limitations To Traditional Vaccines:
1. Can not grow all organisms in
culture
2. Expense
3. Insufficient attenuation
4. Reversion to infectious state
5. Need refrigeration
6. Do not work for all infectious
agents
7. Immature immunity for
infants/children.
11. New Generation of Vaccines:
• Recombinant DNA technology is being used to
produce a new generation of vaccines.
Virulence genes are deleted and organism is still
able to stimulate an immune response.
Live nonpathogenic strains can carry antigenic
determinants from pathogenic strains.
If the agent cannot be maintained in culture, genes
of proteins for antigenic determinants can be cloned
and expressed in an alternative host e.g. E. coli.
12.
13. INTRODUCTIONINTRODUCTION
DNA vaccine is DNA sequence used as a
vaccine.
This DNA Sequence code for antigenic
protein of pathogen.
As this DNA inserted into cells it is
translated to form antigenic protein. As
this protein is foreign to cells, so
immune response raised against this
protein.
In this way, DNA vaccine provide
immunity against that pathogen.
14. DNA vaccinesVsTraditional vaccinesDNA vaccinesVsTraditional vaccines
DNA vaccines Traditional vaccines
Uses only the DNA from
infectious organisms.
Avoid the risk of using
actual infectious
organism.
Provide both Humoral &
Cell mediated immunity
Refrigeration is not
required
Uses weakened or killed
form of infectious
organism.
Create possible risk of
the vaccine being fatal.
Provide primarily
Humoral immunity
Usually requires
Refrigeration.
15. HOW DNAVACCINE IS MADE
Viral gene
Expression
plasmid
Plasmid with foreign gene
Recombinant DNA
Technology
19. ADVANTAGES
1. Produce both Humoral & cell mediated
immunity
2. Focused on Antigen of interest
2. Long term immunity
3. Refrigeration is not required
4. Stable for storage
20. DISADVANTAGES
1. Limited to protein immunogen only
2. Extended immuno stimulation leads to chronic
inflammation
3. Some antigen require processing which
sometime does not occur.
23. Types ofVaccination
• Active:
Protection produced by the person's own immune
system, longer time and may be long lasting.
• Natural : eg – Infection
• Artificial : eg –Vaccination
• Passive: Protection transferred from another person
or animal,Temporary wanes out by time.
• Natural,
Examples: IgG crossing placenta to protect fetus
Antibodies acquired by baby through breast milk.
• Artificial
Examples:Treatment with antiserum, antitoxin.
24. Monoclonal antibody
• Derived from a single type, or clone, of
antibody-producing cells (B cells)
• Antibody is specific to a single antigen or
closely related group of antigens
• Used for diagnosis and therapy of certain
cancers and autoimmune and infectious
diseases
25. Types of Active vaccines
•Living attenuated; virus or
bacteria
•Killed or Inactivated; Whole
(Virus or Bacteria).
•Fractionated
•protein-based ( e.g. toxoid )
•polysaccharide-based
26. 1. Live attenuatedVaccines
• Attenuated (weakened) form of the "wild" virus or
bacterium
• Must replicate to be effective
• Immune response similar to natural infection
• Usually produce immunity with one dose, except those
administered orally
• Severe reactions possible
• Interference from circulating antibody
• Fragile – must be stored and handled carefully
• Viral:
• measles, mumps,rubella, varicella/zoster, yellow fever, rotavirus
etc..
• Bacterial BCG, oral typhoid
27. 2. InactivatedVaccines
• Cannot replicate
• Generally not as effective as live vaccines
• Less interference from circulating antibody than live vaccines
• Generally require 3-5 doses
• Immune response mostly humoral
• Antibody titre may diminish with time
• Whole cell vaccine
• Viral polio, hepatitis A, rabies, influenza
• Bacterial: pertussis, typhoid, cholera, plague
• Fractionated
• Subunit hepatitis B, influenza, acellular pertussis,human
papillomavirus, anthrax
• Toxoid: diphtheria, tetanus
28. Pure PolysaccharideVaccines
• Not consistently immunogenic in children younger than 2
years of age
• No booster response
• Antibody with less functional activity
• Immunogenicity improved by conjugation
29. Polysaccharide Vaccines
• Pure polysaccharide
• pneumococcal
• meningococcal
• SalmonellaTyphi (Vi
• Conjugate polysaccharide
•Haemophilus influenzae type b
•pneumococcal
•meningococcal
30. DNA vaccine
• Is a coding DNA sequence used as a vaccine when injected
into cells, it is translated to form antigenic protein of
pathogens. As this protein is foreign to cells , so immune
response raised against this protein.
• Advantages over traditional vaccines:
• Uses only the DNA from infectious organisms.
• Avoid the risk of using actual infectious organism.
• Provide both Humoral & Cell mediated immunity
• Refrigeration is not required
• Expressed inside cell, so no problem with all kinetics
• Disadvantages:
Limited to protein immunogen only
Extended immunostimulation leads to chronic inflammation
Some antigen require processing which sometime does not occur
31. Nucleic Acid (DNA)Vaccination
• Nucleic acid (DNA) vaccination is a technique for
stimulation of the immune response against a disease
causing agent by injecting the genetically engineered
DNA of it to create protection .
• This technique is still under investigation, and it has been
applied to a number of viral, bacterial and parasitic
models of disease, as well as to several tumour models.
• Although DNA vaccines are untested in the clinical
setting, they have a number of potential advantages over
conventional vaccines, including the ability to induce a
wider range of immune response types and no risk for
infection
40. When the virus enters body second time
Viral Protein
Memory T-Cell
Antibodies
41. Current DNA vaccine clinical trials.
Ferraro B et al. Clin Infect
Dis. 2011;53:296-302
42. Toxoids
Toxoids made by inactivating the toxin that
some infectious agents create.
Toxoids used against Tetanus and Diphtheria.
Advantages Disadvantages
- You only have to have
the vaccine once or
twice.
- They will never be
reactivated and cause
the disease.
- They have to be
refrigerated.
43. Subunit Vaccines
Made by taking apart an infectious agent and only
using the antigenic part (the part that stimulates
an immune response).
Example vaccines: Hepatitis B and Streptococcus
pneumoniae
Advantages Disadvantages
- They cannot cause
the disease.
- They are more difficult to
make and require new,
expensive technology.
Editor's Notes
For more information, see the Bodily Defenses module in the Organ Systems Web curriculum at peer.tamu.edu
Knowledge
Knowledge
Current DNA vaccine clinical trials. At the time of publication, 43 clinical trials evaluating DNA vaccines were listed as on-going in the clinicaltrials.gov database. The large pie chart shows the percentage of trials by vaccine target. The inset pie chart shows the percentage of trials targeting specific cancers among the 29% of clinical trials that are cancer related. HIV, human immunodeficiency virus; HPV, human papillomavirus.